rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2004-3-4
|
pubmed:abstractText |
Investigations of glycoprotein (GP) IIb/IIIa inhibition in primary percutaneous coronary intervention (PCI) have suggested the efficacy of abciximab in improving clinical and angiographic outcomes, but sample-size limitations and variability in trial design preclude the ability to generalize these results to a broader patient population.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1097-6744
|
pubmed:author |
pubmed-author:BrenerSorin JSJ,
pubmed-author:CaliffRobert MRM,
pubmed-author:HarringtonRobert ARA,
pubmed-author:HasselbladVicV,
pubmed-author:KandzariDavid EDE,
pubmed-author:KastratiAdnanA,
pubmed-author:KongDavid FDF,
pubmed-author:MontalescotGillesG,
pubmed-author:NeumannFranz-JosefFJ,
pubmed-author:StoneGregg WGW,
pubmed-author:TchengJames EJE
|
pubmed:issnType |
Electronic
|
pubmed:volume |
147
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
457-62
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:14999194-Angioplasty, Balloon, Coronary,
pubmed-meshheading:14999194-Antibodies, Monoclonal,
pubmed-meshheading:14999194-Hemorrhage,
pubmed-meshheading:14999194-Humans,
pubmed-meshheading:14999194-Immunoglobulin Fab Fragments,
pubmed-meshheading:14999194-Myocardial Infarction,
pubmed-meshheading:14999194-Platelet Aggregation Inhibitors,
pubmed-meshheading:14999194-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:14999194-Proportional Hazards Models,
pubmed-meshheading:14999194-Randomized Controlled Trials as Topic,
pubmed-meshheading:14999194-Recurrence,
pubmed-meshheading:14999194-Stents
|
pubmed:year |
2004
|
pubmed:articleTitle |
Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials.
|
pubmed:affiliation |
Division of Cardiology, Department of Medicine, Duke University Medical Center and Duke Clinical Research Institute, Durham, NC 27715, USA. kandz002@mc.duke.edu
|
pubmed:publicationType |
Journal Article,
Review,
Meta-Analysis
|